1h04
From Proteopedia
| Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
Decay-accelerating factor (CD55), a regulator of the alternative and, classical pathways of complement activation, is expressed on all, serum-exposed cells. It is used by pathogens, including many enteroviruses, and uropathogenic Escherichia coli, as a receptor prior to infection. We, describe the x-ray structure of a pathogen-binding fragment of human CD55, at 1.7 A resolution containing two of the three domains required for, regulation of human complement. We have used mutagenesis to map biological, functions onto the molecule; decay-accelerating activity maps to a single, face of the molecule, whereas bacterial and viral pathogens recognize a, variety of different sites on CD55. | Decay-accelerating factor (CD55), a regulator of the alternative and, classical pathways of complement activation, is expressed on all, serum-exposed cells. It is used by pathogens, including many enteroviruses, and uropathogenic Escherichia coli, as a receptor prior to infection. We, describe the x-ray structure of a pathogen-binding fragment of human CD55, at 1.7 A resolution containing two of the three domains required for, regulation of human complement. We have used mutagenesis to map biological, functions onto the molecule; decay-accelerating activity maps to a single, face of the molecule, whereas bacterial and viral pathogens recognize a, variety of different sites on CD55. | ||
| + | |||
| + | ==Disease== | ||
| + | Known diseases associated with this structure: Blood group Cromer OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=125240 125240]], Blood group, Knops system OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=120620 120620]], CR1 deficiency OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=120620 120620]], Malaria, severe, resistance to OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=120620 120620]], SLE susceptibility OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=120620 120620]] | ||
==About this Structure== | ==About this Structure== | ||
| Line 30: | Line 33: | ||
[[Category: ligand for cd97]] | [[Category: ligand for cd97]] | ||
| - | ''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov | + | ''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 17:11:01 2007'' |
Revision as of 15:04, 12 November 2007
|
HUMAN CD55 DOMAINS 3 & 4
Contents |
Overview
Decay-accelerating factor (CD55), a regulator of the alternative and, classical pathways of complement activation, is expressed on all, serum-exposed cells. It is used by pathogens, including many enteroviruses, and uropathogenic Escherichia coli, as a receptor prior to infection. We, describe the x-ray structure of a pathogen-binding fragment of human CD55, at 1.7 A resolution containing two of the three domains required for, regulation of human complement. We have used mutagenesis to map biological, functions onto the molecule; decay-accelerating activity maps to a single, face of the molecule, whereas bacterial and viral pathogens recognize a, variety of different sites on CD55.
Disease
Known diseases associated with this structure: Blood group Cromer OMIM:[125240], Blood group, Knops system OMIM:[120620], CR1 deficiency OMIM:[120620], Malaria, severe, resistance to OMIM:[120620], SLE susceptibility OMIM:[120620]
About this Structure
1H04 is a Single protein structure of sequence from Homo sapiens with NI as ligand. Structure known Active Site: AC1. Full crystallographic information is available from OCA.
Reference
Mapping CD55 function. The structure of two pathogen-binding domains at 1.7 A., Williams P, Chaudhry Y, Goodfellow IG, Billington J, Powell R, Spiller OB, Evans DJ, Lea S, J Biol Chem. 2003 Mar 21;278(12):10691-6. Epub 2002 Dec 22. PMID:12499389
Page seeded by OCA on Mon Nov 12 17:11:01 2007
Categories: Homo sapiens | Single protein | Billington, J. | Chaudhry, Y. | Evans, D.J. | Goodfellow, I. | Lea, S.M. | Spiller, B. | Williams, P. | NI | Alternative splicing | Bacterial receptor | Complement decay accelerating factor | Complement pathway | Enteroviral receptor | Gpi-anchor | Ligand for cd97
